NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-209-2008-0-GB-14 USE OF MIR-26 FAMILY AS A PREDICTIVE MARKER OF HEPATOCELLULAR CARCINOMA AND RESPONSIVENESS TO THERAPY GB EP 09763590.8 Abandoned
NCI E-209-2008-0-PCT-02 MicroRNAS As Predictors For Hepatocellular Carcinoma With Poor Outcomes And Responses To Interferon Therapy PCT PCT PCT/US2009/046999 Expired
NCI E-209-2008-0-CA-03 MicroRNAS As Predictors For Hepatocellular Carcinoma With Poor Outcomes And Responses To Interferon Therapy CA National Stage 2727633 Abandoned
NIAID E-224-2009-0-US-01 GARP (LRRC32) is Essential for the Surface Expression of Latent TGF-B US 61/185,933 Abandoned
NIDA E-027-2010-0-US-01 Useof A Small Peptide DADLE In Treating Stroke US 61/185,853 Abandoned
NIDDK E-226-2009-0-US-01 STAMP Affects The Growth Of Transformed And Ovarian Cancer Cell US 61/185,503 Abandoned
NCI E-093-2009-0-US-01 Polyphenol, Beta-Lactam, and Porphyrin Compounds as Inhibitors of TDP1 and Methods of Treating Disorders US 61/268,130 Abandoned
NCI E-256-2008-0-EP-04 Survival Predictor For Diffuse Large B Cell Lymphoma EP National Stage 09759517.7 Issued
NCI E-256-2008-0-IT-12 Survival Predictor For Diffuse Large B Cell Lymphoma IT EP 09759517.7 Issued
NCI E-256-2008-0-ES-09 Survival Predictor For Diffuse Large B Cell Lymphoma ES EP 09759517.7 Issued
NCI E-256-2008-0-GB-11 Survival Predictor For Diffuse Large B Cell Lymphoma GB EP 09759517.7 Issued
NCI E-256-2008-0-DE-08 Survival Predictor For Diffuse Large B Cell Lymphoma DE EP 09759517.7 Issued
NCI E-256-2008-0-FR-10 Survival Predictor For Diffuse Large B Cell Lymphoma FR EP 09759517.7 Issued
NCI E-321-2006-0-US-03 Regulation Of Skin Characteristics By Dickkopf 1 (DKK1) US National Stage 12/518,052 8198244 Abandoned PDF
NCI E-062-1996-0-US-12 PROSTATE SPECIFIC ANTIGEN OLIGO-EPITOPE PEPTIDE US CON 12/479,292 7871986 Expired PDF
NCI E-256-2008-0-PCT-02 A Gene Expression-based Survival Predictor For Diffuse Large B Cell Lymphoma Treated With Chemotherapy Plus Rituximab PCT PCT PCT/US2009/046421 Expired
NCI E-256-2008-0-EP-07 Survival Predictor For Diffuse Large B Cell Lymphoma EP DIV 15180558.7 Abandoned
CC E-228-2009-0-US-01 System And Method Of Integrated Biopsy And Therapy US 61/184,322 Abandoned
NCI E-194-2008-0-PCT-02 Immunotoxins and Uses Thereof PCT PCT PCT/US09/46292 Expired
NCI E-226-2006-0-US-03 METHOD OF PREPARING MACROMOLECULAR CONTRAST AGENTS AND USES THEREOF US National Stage 12/513,813 8288530 Abandoned PDF
NIAID E-173-2004-1-US-10 Method of Using Adenoviral Vectors to Induce an Immune Response US CON 12/477,712 Abandoned
NIAID E-326-2006-1-US-03 Codon Modified Immunogenic Compositions and Methods of Use US National Stage 12/517,194 8772256 Abandoned PDF
NCI E-259-2008-0-PCT-02 METHODS AND MATERIALS FOR IDENTIFYING PATIENTS AT HEIGHTENED RISK FOR DEVELOPING HER2+ RELATED BRAIN TUMORS PCT PCT PCT/US2009/003330 Expired
NCI E-157-2009-0-US-01 The Discovery And Validation Of MDR1-inverse Agents US 61/182,511 Abandoned
NIAID E-110-2006-0-US-03 Use Of Muramyl Dipeptide (MDP) For Treating Inflammation US National Stage 12/516,633 8603978 Issued PDF
NCI E-013-2002-0-US-07 Nucleic Acids Encoding Humanized Anti-Tag 72 CC49 Antibodies US DIV 12/474,221 7919607 Abandoned PDF
NCI E-178-2009-0-US-01 A Dual Function Protein, ATIA, Is A Novel Diagnostic Marker For Human Glioblastoma And A Potential Therapeutic Target For Treating The Disease US 61/182,072 Abandoned
NIAID E-078-2009-0-US-01 Development Of Antigenic Chimeric Tick-borne Encephalitis Virus/dengue Virus Type 4 Recombinant Viruses (TBEV/DEN4) As Vaccine Candidates For The Prevention Of Disease Caused By TBEV US 61/181,982 Abandoned
NIAID E-218-2008-0-US-02 METHOD FOR IDENTIFICATION OF T-LYMPHOCYTE ANTIGENS US ORD 12/473,096 Abandoned
CC E-066-2010-0-JP-06 SYSTEM AND METHOD FOR FUSING REAL-TIME ULTRASOUND IMAGES WITH PRE-ACQUIRED MEDICAL IMAGES JP National Stage 2009-537754 Abandoned
NICHD E-158-1998-0-US-09 VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION US DIV 12/471,049 8168195 Abandoned PDF
CC E-063-2008-1-PCT-01 Use Of Functionalized Higher Generation (G) Dendrimer Nanoparticles (G5, G6 And G7) With A Neutralized Exterior For Imaging And Treatment Of Malignant Solid Tumors (cancers) Via Intravenous Administration PCT PCT COMB PCT/US2009/003164 Expired
NIA E-134-2009-0-US-01 Engineering Rhythmic And Responsive Biological Pacemakers Based on The Enhancement Of Cell Intracellular Signaling Targeting Both Ca Cycling And Sarcolemma US 61/180,491 Abandoned
NCI E-191-2009-0-US-01 Akt-Ser473 Phosphorylation And Taxane-Based Chemotherapy US 61/180,558 Abandoned
NCI E-207-2009-0-US-01 New Processes For Preparation Of Dendrimer-Based Bifunctional Diethylenetriaminepentaacetic Acid And DOTA Gd(III) MR Contrast Agent Derivatives US 61/180,327 Abandoned
NCI E-182-2008-0-PCT-02 Use Of Suppressive Oligonucleotides To Prevent/treat Silicosis And Asbestosis PCT PCT PCT/US2009/044739 Expired
NCI E-182-2008-0-EP-03 Method of Treating Pneumoconiosis With oligodeoxynucleotides EP National Stage 09751520.9 Abandoned
NCI E-274-2009-0-US-01 A Novel Tool To Evaluate Fetal Health. US 61/170,742 Abandoned
NCI E-316-2008-0-US-02 Methods And Systems Using Therapeutic, Diagnostic or Prophylactic Magnetic Agents US ORD 12/468,746 8579787 Abandoned PDF
NCI E-192-2009-0-US-01 Prevention Of Tumor Recurrence Through Inhibition Of Fibrosis, Integrin Signaling, Src And ERK Activation And Actin Stress Fiber Formation. US 61/179,641 Abandoned
NIDDK E-015-1996-0-US-20 HUMAN LUTEINIZING HORMONE SUPERAGONISTS US DIV 12/467,081 8044187 Abandoned PDF
NCI E-091-2008-0-PCT-02 Development Of A Highly Sensitive ELISA-based Polo-like Kinase 1 (Plk1) Activity Assay PCT PCT PCT/US2009/044202 Expired
NCI E-163-2009-0-US-01 A Panel Of Fully Human Monoclonal Antibodies To The Same Epitope Of An Unknown Cell Surface Antigen Expressed In B-cell Lymphocytic Leukemia (B-CLL) US 61/178,688 Abandoned
NCI E-181-2009-0-US-01 Development Of Peptide Mimetic Ligands Of Polo-like Kinase L Polo Box Domain US 61/178,593 Abandoned
NHLBI E-249-2006-2-US-03 Transcatheter Coronary Sinus Mitral Valve Annuloplasty Procedure And Coronary Artery And Myocardial Protection Device US National Stage 12/514,990 8211171 Issued PDF
NCI E-258-2008-0-PCT-02 OXOBENZINDOLIZINOQUINOLINES AND USES THEREOF PCT PCT PCT/US2009/043905 Abandoned
NCATS E-187-2009-0-US-01 Development Of Inhibitors Of The Alpha IIb Beta 3 Receptor. US 61/178,483 Abandoned
NCI E-193-2009-0-US-01 A 50-gene Predictor Of Chemoresistance US 61/178,392 Abandoned
NCI E-257-2008-0-JP-31 Melanoma Associated Peptide Analogues And Vaccines Against Melanoma JP DIV 2009-115844 Expired
NIMH E-155-2008-1-PCT-01 Radiotracers For Imaging Cannabinoid Sub-Type 1 (CB-1) Receptor PCT PCT COMB PCT/US2009/043491 Expired